* BIO-Key International Inc BKYI.OQ BKYI.O is expected
to show a rise in quarterly revenue when it reports results on
August 16.
* The Wall Township, New Jersey-based company is expected to
report a 453.5% increase in revenue to $1.7 million from
$307.14 thousand a year ago, according to the estimate from one
analyst, based on Refinitiv data.
* Refinitiv's mean analyst estimate for BIO-Key International
Inc is for a loss of 11 cents per share. For the same quarter
last year, the company reported a loss of 56 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for BIO-Key
International Inc is $6, about 44.8% above its last closing
price of $3.31.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.16 -0.16 -0.09 Beat 43.8
Dec. 31 2020 -0.16 -0.18 Missed -12.5
Sep. 30 2020 -0.08 -0.08 -0.48 Missed -500
Jun. 30 2020 -0.24 -0.24 -0.56 Missed -133.3
Mar. -0.40 -1.44 Missed -260
31 2020
Dec. 31 2019 -0.24 -1.36 Missed -466.7
Sep. 30 2019 -0.40 -0.40 -1.04 Missed -160
Jun. 30 2019 -0.40 -0.40 -0.56 Missed -40
This summary was machine generated August 10 at 12:58 GMT. All
figures in US dollars unless otherwise stated